GILD

Gilead Sciences, Inc. News Headlines

$89.84
*  
0.70
0.77%
Get GILD Alerts
*Delayed - data as of Jul. 25, 2014  -  Find a broker to begin trading GILD now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Market Ignores AbbVie's Impressive Sales Due To Reliance On Humira
7/26/2014 3:05:00 AM - Seeking Alpha

Noteworthy ETF Inflows: XLV, MRK, GILD, CELG
7/25/2014 11:13:51 AM - BNK Invest

ROTH Capital's Debjit Chattopadhyay: Marriage Of Diagnostics To New Therapies Breeds Biotech Winners
7/25/2014 10:52:00 AM - Seeking Alpha

Gilead Sciences Gets Positive CHMP Opinion For Zydelig - Quick Facts
7/25/2014 7:30:00 AM - RTT News

Alexion Pharmaceuticals Q2 Earnings In Line; Revises View - Analyst Blog
7/24/2014 3:45:00 PM - Zacks.com

A Re-Analysis Of Gilead After Q2 Results And The Early Idelalisib Approval
7/24/2014 1:50:00 PM - Seeking Alpha

Healthcare Spending to Trend Up in 2015: 3 Healthcare Fund Picks - Best of Funds
7/24/2014 1:48:13 PM - Zacks.com

Gilead: Even This Raging Bull Was Too Pessimistic
7/24/2014 12:30:00 PM - Seeking Alpha

Why Gilead Is A Better Buy Than This Rival
7/24/2014 11:26:00 AM - Seeking Alpha

Gilead Sciences Q2 2014: All Is Good, More To Come At Medical Conferences Later This Year
7/24/2014 11:25:00 AM - Seeking Alpha

Gilead Sciences - Sovaldi Momentum Continues, Appeal Remains
7/24/2014 10:28:00 AM - Seeking Alpha

Gilead Crushes Q2 Earnings Estimates as Sovaldi Sales Soar - Analyst Blog
7/24/2014 9:50:00 AM - Zacks.com

Gilead: Sovaldi Delivers Q2 Product Sales Of $3.5B... Enough Said
7/24/2014 9:43:00 AM - Seeking Alpha

MARKET SNAPSHOT: U.S. Stocks: Futures Up; Jobless Claims Tumble
7/24/2014 9:06:00 AM - Dow Jones Business News

Update: Gilead Sciences Earnings
7/24/2014 8:21:00 AM - Seeking Alpha

MARKET SNAPSHOT: U.S. Stocks: Futures Up As Ford, Facebook Rise Premarket
7/24/2014 7:01:00 AM - Dow Jones Business News

Cramer's Mad Money: The 4 Horsemen Trample Big Pharma (7/23/14)
7/24/2014 6:01:00 AM - Seeking Alpha

MARKET SNAPSHOT: U.S. Stocks: Futures Up With Eyes On Ford, Facebook
7/24/2014 6:00:00 AM - Dow Jones Business News

Gilead Announces New Agreement With MPP On HIV Experimental Drug
7/24/2014 12:21:00 AM - RTT News

Are Growth Stocks Appropriate For Retirement Portfolios?
7/23/2014 5:46:00 PM - Seeking Alpha

After Hours Most Active for Jul 23, 2014 : FB, MDAS, QQQ, GILD, QCOM, F, ARIA, T, XRX, CX, BID, ABBV
7/23/2014 4:39:57 PM - NASDAQ.com News

Gilead Sciences Q2 Profit Soars On Sovaldi Sales - Quick Facts
7/23/2014 4:34:00 PM - RTT News

Gilead Sciences Q2 14 Earnings Conference Call At 4:30 PM ET
7/23/2014 3:00:00 PM - RTT News

This Is What Happens When A New Drug Hits The Market And Nobody Knows What To Expect
7/23/2014 2:27:00 PM - Seeking Alpha

Biotech Stock Roundup: AbbVie's Tax Inversion, Amgen Drug Scores in Phase 3 - Analyst Blog
7/23/2014 2:15:00 PM - Zacks.com